Sullivan Tiffany
Known title: DirectorCIK: 0001876368
Associated companies
Transaction History
| LUNG | ▲ Buy | Grant | 40,000 | $0 | 6/5/2026 | View on chart |
| LUNG | ▲ Buy | Grant | 37,153 | $0 | 6/2/2025 | View on chart |
| LUNG | ▲ Buy | Grant | 15,216 | $0 | 6/3/2024 | View on chart |
| LUNG | ▲ Buy | Grant | 12,620 | $0 | 6/1/2023 | View on chart |
| LUNG | ▲ Buy | Grant | 5,600 | $0 | 6/1/2022 | View on chart |
| LUNG | ▲ Buy | Grant | 4,610 | $0 | 9/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Pulmonx Sets Q3 2026 Earnings Date for October 27
Pulmonx Corporation has announced that it will report its third-quarter 2026 financial results on October 27, 2026. This scheduled update provides a specific timeline for investors to review the company's latest performance metrics. The announcement serves as a standard corporate disclosure rather than a change in business operations.
Pulmonx Sets Q3 2026 Earnings Date for October 27. Pulmonx Corporation has announced that it will report its third-quarter 2026 financial results on October 27, 2026. This scheduled update provides a specific timeline for investors to review the company's latest performance metrics. The announcement serves as a standard corporate disclosure rather than a change in business operations.